GfK’s Vanderveer warns of health risks to pharma MR agencies

US— Pharmaceutical market research agencies “as we know them” may be living on borrowed time, suggests GfK Healthcare CEO Richard Vanderveer.

Writing in the company’s newsletter, he says recent events, marketplace experiences and conversations at conferences “could readily lead one to conclude that it is increasingly difficult to maintain a viable business as an agency focusing on the conduct of high quality pharmaceutical marketing research”.

Vanderveer’s comments were prompted in part by news of the planned closure of TVG, the business he founded in 1979 as The Vanderveer Group. TVG’s owner, the healthcare marketing services firm PDI, plans to exit the market research business by the end of August – though TVG management is in talks to buy the brand and continue trading independently.

Healthcare company mergers, healthcare reform, a “dearth” of new drugs being marketed and patent expiry of existing blockbuster agents are all lessening demand for market research, while procurement departments are taking much of the profit out of those research projects that are being commissioned, says Vanderveer.

“Put all this together and one can begin to foresee a world devoid of pharmaceutical marketing research agencies as we know them, as groups of various sizes and shapes are sequentially required to close their doors based on an ever-tightening squeeze on profitability,” he warns.

Read Vanderveer’s comments in full here.

We hope you enjoyed this article.
Research Live is published by MRS.

The Market Research Society (MRS) exists to promote and protect the research sector, showcasing how research delivers impact for businesses and government.

Members of MRS enjoy many benefits including tailoured policy guidance, discounts on training and conferences, and access to member-only content.

For example, there's an archive of winning case studies from over a decade of MRS Awards.

Find out more about the benefits of joining MRS here.

0 Comments


Display name

Email

Join the discussion

Newsletter
Stay connected with the latest insights and trends...
Sign Up
Latest From MRS

Our latest training courses

Our new 2025 training programme is now launched as part of the development offered within the MRS Global Insight Academy

See all training

Specialist conferences

Our one-day conferences cover topics including CX and UX, Semiotics, B2B, Finance, AI and Leaders' Forums.

See all conferences

MRS reports on AI

MRS has published a three-part series on how generative AI is impacting the research sector, including synthetic respondents and challenges to adoption.

See the reports

Progress faster...
with MRS 
membership

Mentoring

CPD/recognition

Webinars

Codeline

Discounts